시장보고서
상품코드
1429571

세계의 비동물 대체품 검사 시장 보고서(2024년)

Non-Animal Alternatives Testing Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

비동물 대체품 검사 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상됩니다. 2028년까지 연평균 11.8%의 복합 성장률(CAGR)로 36억 3,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 비동물대체시험을 지원하는 정부의 노력, 연구개발 활동의 증가, 동물실험에 대한 윤리적 유보 등이 모두 시장 확대에 기여할 것으로 보입니다. 이 기간 동안 예상되는 주요 동향으로는 오가노이드(OOC) 기술의 발전, 비실리콘 시험의 활용, 첨단 3D 바이오프린트 장기 및 조직 개발, 모델 생물체 통합, 전략적 협력 및 파트너십의 중요성 등이 있습니다. 동물을 사용하지 않는 검사를 촉진하기 위한 노력과 보조금이 급증하고 있습니다.

비동물 검사 시장의 성장은 정부와 비정부기구의 지원에 힘입어 성장하고 있습니다. 정부 기관은 규정을 시행하고, 법을 제정하고, 인간 자원 봉사자에 대한 검사 및 고급 컴퓨터 모델링 기술과 같은 비동물 검사 방법을 지원하기 위해 자금을 할당하고 있습니다. 예를 들어, 동물의 윤리적 대우를 요구하는 사람들(PETA) 인도는 2022년에 70만 루피의 보조금을 발표하여 동물을 사용하지 않는 독극물 검사법을 장려하기 위한 노력을 표명했습니다. 비동물 검사 절차를 장려하기 위한 유사한 노력은 다음과 같은 국가에서도 시행되고 있습니다. 덴마크, 브라질, 독일, 스위스, 호주, 중국, 한국 등 국가. 정부 및 비정부 기관의 일관된 지원은 비동물 검사 시장의 성장을 촉진하는 데 매우 중요한 역할을 할 것입니다.

비동물 대체품 검사 시장의 예상 확대는 향후 의료비 증가로 인해 촉진될 것으로 예상됩니다. 의료비 지출을 포함한 의료비 지출은 특정 의료 시스템 또는 경제 내에서 의료 관련 상품 및 서비스에 대한 총 재정적 투자를 반영합니다. 이 지출은 동물을 사용하지 않는 대체 검사 활동의 개발과 접근성을 촉진하는 데 도움이 될 수 있습니다. 일례로 캐나다 보건 정보 연구소가 발표한 2022년 11월 데이터에 따르면 2022년 의료 지출이 0.8% 증가하여 2021년 7.6%에 비해 2022년 3,310억 달러에 달할 것으로 예상했습니다. 그 결과 의료비 지출은 증가 추세에 있습니다.는 비동물 대체품 검사 시장의 성장에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계의 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 규모 실적과 성장, 2018-2023년
  • 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 비동물 대체품 검사 시장, 기술별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세포배양 기술
  • 하이 스루풋 기술
  • 분자 이미징
  • 오믹스 기술
  • 기타 기술
  • 세계의 비동물 대체품 검사 시장, 방법별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세포 어세이
  • 생화학적 어세이
  • In Silico
  • Ex-vivo
  • 세계의 비동물 대체품 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 제약 산업
  • 화장품 및 가정용품
  • 진단
  • 화학 산업
  • 식품 업계

제7장 지역 및 국가 분석

  • 세계의 비동물 대체품 검사 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 비동물 대체품 검사 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

  • 비동물 대체품 검사 시장 경쟁 상황
  • 비동물 대체품 검사 시장 기업 개요
    • Evotec SE(Cyprotex)
    • Bio-Rad Laboratories, Inc
    • BioIVT
    • Emulate, Inc
    • MatTek Corporation

제31장 기타 주요 및 혁신적인 기업

  • SGS SA
  • Gentronix Limited
  • Promega Corporation
  • InSphero
  • VITROCELL Systems GmbH
  • Abbott India Limited
  • Becton Dickinson Private Limited
  • Biocartis Group NV
  • Bio-Techne India Private Limited
  • Danaher
  • Cleaver Scientific
  • China Tissue Engineering Co., Ltd.(J-TEC)
  • Reprocell, Inc.
  • Organ Technologies Co. Ltd
  • Mimetas

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병

제35장 향후 전망과 가능성 분석

제36장 부록

ksm 24.03.21

Non-animal alternative testing refers to the evaluation of products and services without resorting to animal testing, aiming to ascertain the safety and effectiveness of various substances across different industry sectors. Technologies employed in non-animal alternative testing encompass in-vitro human cell and tissue cultures, organs-on-chips (OOCs), computer simulations, 3D bio-printing of tissues, synthetic skin substitutes, and studies involving human volunteers. These advanced methods serve as substitutes for animal testing across diverse industries, including pharmaceuticals, medical devices, chemicals, pesticides, food, and more.

The primary techniques in non-animal alternative testing include cellular assay, biochemical assay, in silico modeling, and ex-vivo methods. A biochemical assay is an analytical process conducted in vitro to detect, quantify, or explore the binding or activity of biological molecules such as enzymes. Various technologies play a crucial role in these methods, including cell culture technology, high-throughput technology, molecular imaging, omics technology, and others. Industries such as pharmaceuticals, cosmetics, household products, diagnostics, chemicals, and food utilize these technologies as alternatives to animal testing.

The non-animal alternatives testing market research report is one of a series of new reports from The Business Research Company that provides non-animal alternatives testing market statistics, including non-animal alternatives testing industry global market size, regional shares, competitors with a non-animal alternatives testing market share, detailed non-animal alternatives testing market segments, market trends and opportunities, and any further data you may need to thrive in the non-animal alternatives testing industry. This non-animal alternatives testing market research report provides a comprehensive view of everything you require, including an in-depth analysis of the industry's current and future scenario.

The non-animal alternatives testing market size has grown rapidly in recent years. It will grow from $2.08 billion in 2023 to $2.33 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The expansion observed in the historical period can be credited to robust economic growth in emerging markets, elevated expenses associated with animal studies, a growing embrace of in-vitro and in-silico technologies in fundamental research, heightened investments, increased research grants dedicated to developing alternative technologies, and a rising societal consciousness opposing animal cruelty.

The non-animal alternatives testing market size is expected to see rapid growth in the next few years. It will grow to $3.63 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The anticipated growth in the forecast period can be ascribed to government initiatives supporting non-animal alternative testing, an increase in research and development activities, and ethical reservations regarding animal experiments, all contributing to market expansion. Key trends expected in this period involve an emphasis on advancing organs-on-chips (OOC) technology, the utilization of in silico trials, the development of advanced 3D bio-printed organs and tissues, the incorporation of model organisms, strategic collaborations and partnerships, and a surge in initiatives and grants aimed at promoting animal-free testing.

The growth of the non-animal testing market is propelled by support from both government and non-governmental organizations. Government entities enforce regulations, enact laws, and allocate funds to endorse non-animal testing methods, including tests on human volunteers and advanced computer-modeling techniques. People for the Ethical Treatment of Animals (PETA) India, for example, demonstrated its commitment to advancing animal-free methods for toxicology testing by announcing a grant of 7 lakh rupees in 2022. Similar initiatives promoting non-animal testing procedures are also undertaken by countries such as Denmark, Brazil, Germany, Switzerland, Australia, China, and Korea. The consistent support from governmental and non-governmental sources plays a pivotal role in driving the growth of the non-animal testing market.

The anticipated expansion of the non-animal alternative testing market is expected to be driven by rising healthcare expenditure in the future. Healthcare expenditure, which encompasses spending on healthcare costs, reflects the total financial investment in healthcare-related goods and services within a specific healthcare system or economy. This expenditure is instrumental in fostering the development and accessibility of non-animal alternative testing activities. As an example, data from November 2022, as reported by the Canadian Institute for Health Information, indicates a rise in healthcare expenditure to 0.8%, amounting to $331 billion in 2022 compared to 7.6% in 2021. Consequently, the upward trajectory in healthcare expenditure is contributing to the growth of the non-animal alternative testing market.

Leading companies in the non-animal alternative testing sector are engaging in collaborations to advance alternatives to animal testing and gain a competitive advantage in the market. These collaborations serve to expedite the adoption of animal-free safety science. For example, in February 2023, Unilever, a UK-based healthcare product manufacturer, partnered with a global coalition of cosmetics manufacturers, suppliers, industry associations, and animal protection organizations. The objective of this collaboration is to promote innovation in animal-free cosmetics, personal care products, and ingredients. The partnership involves funding and scientific evaluation of new safety assessment approaches, aiming to instill confidence in animal-free safety science.

Major companies in non-animal alternative testing are also spearheading the development of innovative products such as Digital Animal Replacement Technology (DART). This technology provides a humane and accurate substitute for animal testing by utilizing ethically sourced human stem cells, a digital workstation, and artificial intelligence to predict drug safety based on stem cell-drug interactions. For instance, in June 2023, Quantifi, a US-based software company, introduced Digital Animal Replacement Technology (DART). This technology not only facilitates early-stage decision-making, cost reduction, and improved time-to-market but also offers advantages such as accelerated testing, customization based on genetic profiles, and relevance to human physiology.

Major companies operating in the non-animal alternatives testing market report are Evotec SE (Cyprotex), Bio-Rad Laboratories, Inc., BioIVT, Emulate, Inc., MatTek Corporation, SGS SA, Gentronix Limited, Promega Corporation, InSphero, VITROCELL Systems GmbH, Abbott India Limited, Becton Dickinson Private Limited, Biocartis Group NV, Bio-Techne India Private Limited, Danaher, Cleaver Scientific, China Tissue Engineering Co., Ltd. (J-TEC), Reprocell, Inc., Organ Technologies Co. Ltd., Mimetas, JRF Global, PharmaCo-Cell Company Ltd., Vessel Inc., Modulus Discovery, Sanofi, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Qiagen N.V, bioMerieux SA, QuantuMDx, Interlabservis, Roche Diagnostics, GeneMe, TestLine Clinical Diagnostics s.r.o, Thermo Fisher Scientific, PerkinElmer, GE Healthcare, Waters Corporation, Agilent Technologies, Bruker Corporation, Oxford Nanopore Technologies, 10x Genomics, Organovo Holdings, EMD Millipore, Cyprotex, RegeneMed Inc., HμREL Corporation, Nortis, In Silico Biosciences Inc., IOMICS Corporation, Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Inc., Cyagen Biosciences, Crown Biosciences, Harbour BioMed, Genewiz, Pacific Biosciences, Group 42 (G42) Healthcare, I-ONE, Wadi Jeddah Co, Philips, King Abdullah International Medical Research Center, Parexel, Soins Global, Pfizer South Africa, Dischem Pharmacy, Cipla Medpro South Africa Limited, Novartis South Africa, Synexa Life Sciences, IQVIA, Oceanic S. A, Hean

North America was the largest region in the non-animal alternatives testing in 2023. Western Europe was the second-largest region in the non-animal alternatives testing market report. The regions covered in the non-animal alternatives testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the non-animal alternatives testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The non-animal alternatives testing market consists of revenue earned by that perform organs-on-chips (OOCs) technology, and 3D bio-printing of tissues among others. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non-Animal Alternatives Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-animal alternatives testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-animal alternatives testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non-animal alternatives testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Technology: Cell Culture Technology; High Throughput Technology; Molecular Imaging; Omics Technology; Other Technologies
  • 2) By Method: Cellular Assay; Biochemical Assay; In Silico; Ex-Vivo
  • 3) By End-User: Pharmaceutical Industry; Cosmetics And Household Products; Diagnostics; Chemicals Industry; Food And Beverage Industry; Other End Users
  • Companies Mentioned: Evotec SE (Cyprotex); Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Non-Animal Alternatives Testing Market Characteristics

3. Non-Animal Alternatives Testing Market Trends And Strategies

4. Non-Animal Alternatives Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Non-Animal Alternatives Testing Market Size and Growth

  • 5.1. Global Non-Animal Alternatives Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Non-Animal Alternatives Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Non-Animal Alternatives Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Non-Animal Alternatives Testing Market Segmentation

  • 6.1. Global Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • Omics Technology
  • Other Technologies
  • 6.2. Global Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cellular Assay
  • Biochemical Assay
  • In Silico
  • Ex-vivo
  • 6.3. Global Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Diagnostics
  • Chemicals Industry
  • Food Industry

7. Non-Animal Alternatives Testing Market Regional And Country Analysis

  • 7.1. Global Non-Animal Alternatives Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Non-Animal Alternatives Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Non-Animal Alternatives Testing Market

  • 8.1. Asia-Pacific Non-Animal Alternatives Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Non-Animal Alternatives Testing Market

  • 9.1. China Non-Animal Alternatives Testing Market Overview
  • 9.2. China Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Non-Animal Alternatives Testing Market

  • 10.1. India Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Non-Animal Alternatives Testing Market

  • 11.1. Japan Non-Animal Alternatives Testing Market Overview
  • 11.2. Japan Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Non-Animal Alternatives Testing Market

  • 12.1. Australia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Non-Animal Alternatives Testing Market

  • 13.1. Indonesia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Non-Animal Alternatives Testing Market

  • 14.1. South Korea Non-Animal Alternatives Testing Market Overview
  • 14.2. South Korea Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Non-Animal Alternatives Testing Market

  • 15.1. Western Europe Non-Animal Alternatives Testing Market Overview
  • 15.2. Western Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Non-Animal Alternatives Testing Market

  • 16.1. UK Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Non-Animal Alternatives Testing Market

  • 17.1. Germany Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Non-Animal Alternatives Testing Market

  • 18.1. France Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Non-Animal Alternatives Testing Market

  • 19.1. Italy Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Non-Animal Alternatives Testing Market

  • 20.1. Spain Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Non-Animal Alternatives Testing Market

  • 21.1. Eastern Europe Non-Animal Alternatives Testing Market Overview
  • 21.2. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Non-Animal Alternatives Testing Market

  • 22.1. Russia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Non-Animal Alternatives Testing Market

  • 23.1. North America Non-Animal Alternatives Testing Market Overview
  • 23.2. North America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Non-Animal Alternatives Testing Market

  • 24.1. USA Non-Animal Alternatives Testing Market Overview
  • 24.2. USA Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Non-Animal Alternatives Testing Market

  • 25.1. Canada Non-Animal Alternatives Testing Market Overview
  • 25.2. Canada Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Non-Animal Alternatives Testing Market

  • 26.1. South America Non-Animal Alternatives Testing Market Overview
  • 26.2. South America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Non-Animal Alternatives Testing Market

  • 27.1. Brazil Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Non-Animal Alternatives Testing Market

  • 28.1. Middle East Non-Animal Alternatives Testing Market Overview
  • 28.2. Middle East Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Non-Animal Alternatives Testing Market

  • 29.1. Africa Non-Animal Alternatives Testing Market Overview
  • 29.2. Africa Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Non-Animal Alternatives Testing Market Competitive Landscape And Company Profiles

  • 30.1. Non-Animal Alternatives Testing Market Competitive Landscape
  • 30.2. Non-Animal Alternatives Testing Market Company Profiles
    • 30.2.1. Evotec SE (Cyprotex)
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bio-Rad Laboratories, Inc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. BioIVT
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Emulate, Inc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. MatTek Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Non-Animal Alternatives Testing Market Other Major And Innovative Companies

  • 31.1. SGS SA
  • 31.2. Gentronix Limited
  • 31.3. Promega Corporation
  • 31.4. InSphero
  • 31.5. VITROCELL Systems GmbH
  • 31.6. Abbott India Limited
  • 31.7. Becton Dickinson Private Limited
  • 31.8. Biocartis Group NV
  • 31.9. Bio-Techne India Private Limited
  • 31.10. Danaher
  • 31.11. Cleaver Scientific
  • 31.12. China Tissue Engineering Co., Ltd. (J-TEC)
  • 31.13. Reprocell, Inc.
  • 31.14. Organ Technologies Co. Ltd
  • 31.15. Mimetas

32. Global Non-Animal Alternatives Testing Market Competitive Benchmarking

33. Global Non-Animal Alternatives Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Non-Animal Alternatives Testing Market

35. Non-Animal Alternatives Testing Market Future Outlook and Potential Analysis

  • 35.1 Non-Animal Alternatives Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Non-Animal Alternatives Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Non-Animal Alternatives Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제